美媒爆：美政府计划通过行政令放宽对大麻管制，白宫官员称“尚未最终决定”

Core Viewpoint - The U.S. government is expected to significantly relax federal regulations on cannabis, aligning its oversight with that of certain common prescription pain medications and other drugs [1][3]. Group 1: Regulatory Changes - President Trump discussed plans to reclassify cannabis during a call with House Speaker Mike Johnson, aiming to ease access restrictions through an upcoming executive order [1][3]. - The reclassification would not legalize cannabis or decriminalize it but would lower research barriers and enhance the legal operating baseline for businesses [3]. Group 2: Political Dynamics - Speaker Johnson expressed skepticism about the reclassification, citing various studies and data against it, while industry executives present during the call attempted to counter his arguments [3]. - The push for cannabis legalization at the federal level is gaining momentum, influenced by interest groups that have spent over $22.4 million on political lobbying related to cannabis from 2018 to 2022 [4]. Group 3: Societal Implications - The increasing legalization of cannabis reflects deeper societal issues related to drug use and abuse in the U.S., with concerns that the normalization of cannabis could exacerbate substance abuse problems [4].